Answers are grounded in this paper and cite their sources.
14-3-3 constitute a highly conserved family of proteins that participate in the regulation of essential cellular processes by establishing extensive protein-protein interactions. Consequently, perturbation of the 14-3-3s interactome can be implicated in the pathogenesis of several diseases. Phosphorylation has emerged as a key mechanism by which 14-3-3s interactome is dynamically regulated, and aberrantly phosphorylated 14-3-3s have been observed in patients with neurological disorders, among which Parkinson’s disease. Here, we investigate the role of Ser59 phosphorylation in 14-3-3γ and its impact on α-Synuclein aggregation by employing both the phosphorylated protein and the S59D phosphomimetic. Consistent with observations reported for other 14-3-3 isoforms, we found that this modification reduces the protective abilities of 14-3-3γ both in vitro and in cellular models. Importantly, this effect is also evident in cerebrospinal fluid (CSF), suggesting that phosphorylation of 14-3-3γ may directly contribute to α-Synuclein aggregation in vivo and may be relevant to disease-associated mechanisms. Using bioinformatics approaches, we further examined how Ser59 phosphorylation reshapes the global 14-3-3γ interactome, revealing novel interaction networks and pathways potentially implicated in neurodegenerative disease pathogenesis.
No takes yet. Share an insight, caveat, or question.
Giusto et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: